CTOs on the Move

NeuBase Therapeutics

www.neubasetherapeutics.com

 
NeuBase is developing ultra precision genetic medicines targeting rare, monogenic diseases, therapeutic candidates for the treatment of myotonic dystrophy type 1 (DM1), Huntington`s disease (HD), and cancer-driving point mutations in KRAS G12V and G12D, which are involved in many tumor types and have historically been “undruggable.” for which there are no approved therapies, as well as more common genetic disorders, including cancers that are resistant to current therapeutic approaches. NeuBase`s pipeline includes
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
Anthony Rossomando
 Chief Technology Officer Profile

Similar Companies

TechLab

TechLab is a Blacksburg, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Rivers Edge Pharmaceuticals

Rivers Edge Pharmaceuticals is a Suwanee, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sovereign Pharmaceuticals

Sovereign Pharmaceuticals is your ideal CDMO partner for your pharma product development, formulation, fill/finish, packaging & commercial manufacturing needs.

TotalAncillary

Comprehensive Solution for Revenue Generating Medical Ancillary Services

WISDOM TRADITIONS COUNSELING SERVICES

Wisdom Traditions is an Integrative Healthcare Center located in Anchorage Alaska. Specializing in Mind/Body approaches, we offer a variety of services ranging from acupuncture, physical therapy and manual medicine to professional counseling, life c...